What is PCAD? A Guide to Primary Cutaneous Anaplastic Large Cell Lymphoma
Primary Cutaneous Anaplastic Large Cell Lymphoma (PCAD/pcALCL) is a rare type of non-Hodgkin lymphoma that develops primarily in the skin. It is classified as an indolent (slow-growing) T-cell lymphoma. Unlike systemic lymphomas, PCAD carries an excellent long-term prognosis.
Understanding the symptoms, diagnosis, and management of PCAD is essential to ensuring proper medical care and preventing unnecessary or aggressive systemic treatments. What Causes PCAD?
PCAD originates from T-lymphocytes, which are white blood cells that usually protect the body from infections. In patients with PCAD, these cells mutate, replicate abnormally, and gather in the upper layers of the skin.
The exact cause of this mutation remains unknown. However, medical researchers focus on specific traits of the disease:
CD30 Positive Marker: The abnormal cells characteristically display a protein on their surface called CD30. This helps differentiate PCAD from other skin disorders.
Demographics: Anyone can develop PCAD, but it is most frequently diagnosed in adults aged 45 to 70 and affects men more often than women.
Non-Contagious: The disease is not hereditary, genetic, or contagious. Recognizing the Symptoms
PCAD typically presents as noticeable changes directly on the surface of the skin. Symptoms include:
Leave a Reply